Overview

A Study of LY2623091 in Male and Females With Chronic Kidney Disease

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate the safety and efficacy of LY2623091 in males and females with chronic kidney disease.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Eplerenone